InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Wednesday, 11/25/2020 6:30:10 PM

Wednesday, November 25, 2020 6:30:10 PM

Post# of 424587
Amarin End-Game:
The end of this tortured investment is finally closing in, thank God! We should all be done with this by the end of January 2022 (closed deal).

1) I think Amarin is Pfizer's by the end of 2021 cash and stock...rumors start @ JPM 2021.https://healthmanagement.org/c/hospital/event/j-p-morgan-39th-annual-healthcare-conference-2021

2) I think the first deal to strike will be a GILD NASH deal between Gilead and Amarin in first week of January 2021. Upfront cash and % royalties for GILD NASH drug.

3) I think Pfizer starts Alzheimer's program with Biogen

4) I think Pfizer will call and take over EU launch ASAP.

5) Pfizer will also take over prosecution of R-I IP in US and launch combination Liptor-Vascepa and rebuild a $10+ billion US sales for combo. Launch of combo 2022-2023.

6) Pfizer will also restart hydroxyl-liptor NCE combo with Vascepa based on superior anti-oxidant LDL properties. Likely a head to head study with Lipitor-Vascepa combo clinical trial that will finish by 2029.

It's happening in 2021, it's closed by end of January 2022....

BB

If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News